business

Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?

Yahoo Finance · Jun 24, 2026, 1:27 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Barclays initiates SAB Biotherapeutics stock at Overweight, PT $13 Investing.com UBS raises Arm Holdings stock price target to $470 on AI chip outlook Investing.com UBS raises AMD stock price target to $670 on server CPU share gains Investing.com Truist raises KB Home stock price target to $56 on margin outlook

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?

Also covered by

More in business